• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secondary hypogammaglobulinemia and lymphocytopenia in patients with inflammatory neurological diseases on anti-CD20 therapy: risk of infection and infection-related mortality.

作者信息

Farooq Abdullah, Ali Mubariz, Malik Ayesha Parvaiz, Sathian Brijesh

机构信息

Lahore Medical and Dental College, Lahore, Pakistan.

CMH Kharian Medical College, Kharian Cantt, Punjab, Pakistan.

出版信息

Neurol Sci. 2025 Sep 19. doi: 10.1007/s10072-025-08514-y.

DOI:10.1007/s10072-025-08514-y
PMID:40968350
Abstract
摘要

相似文献

1
Secondary hypogammaglobulinemia and lymphocytopenia in patients with inflammatory neurological diseases on anti-CD20 therapy: risk of infection and infection-related mortality.接受抗CD20治疗的炎性神经系统疾病患者的继发性低丙种球蛋白血症和淋巴细胞减少症：感染风险及感染相关死亡率
Neurol Sci. 2025 Sep 19. doi: 10.1007/s10072-025-08514-y.
2
Secondary hypogammaglobulinemia and lymphocytopenia in patients with inflammatory neurological diseases on anti-CD20 therapy: risk of infection and infection-related mortality.接受抗CD20治疗的炎性神经疾病患者的继发性低丙种球蛋白血症和淋巴细胞减少症：感染风险及感染相关死亡率
Neurol Sci. 2025 Jul 5. doi: 10.1007/s10072-025-08329-x.
3
[Clinical study on intravenous human immunoglobulin (pH4) for hypogammaglobulinemia and infection risk following CD20 monoclonal antibody therapy in patients with B-cell non-Hodgkin lymphoma].静脉注射人免疫球蛋白（pH4）治疗B细胞非霍奇金淋巴瘤患者CD20单克隆抗体治疗后低丙种球蛋白血症及感染风险的临床研究
Zhonghua Xue Ye Xue Za Zhi. 2025 May 14;46(5):425-430. doi: 10.3760/cma.j.cn121090-20240918-00353.
4
Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy.评估长期静脉用抗 CD20 抗体治疗的法国多发性硬化症队列中的持续 B 细胞耗竭和疾病活动。
Neurotherapeutics. 2023 Oct;20(6):1707-1722. doi: 10.1007/s13311-023-01446-5. Epub 2023 Oct 26.
5
Longitudinal quantification of serum SARS-CoV-2 neutralising antibodies, pro-inflammatory cytokines, NfL and GFAP before and after breakthrough COVID-19 infection in CNS neuroimmunological diseases: a prospective observational study.中枢神经系统神经免疫疾病中突破性新冠病毒感染前后血清新冠病毒-2中和抗体、促炎细胞因子、神经丝轻链和胶质纤维酸性蛋白的纵向定量：一项前瞻性观察研究
Ther Adv Infect Dis. 2025 Sep 9;12:20499361251370471. doi: 10.1177/20499361251370471. eCollection 2025 Jan-Dec.
6
The Real World Impact of Immunoglobulin Replacement Therapy on Severe Bacterial Infection for Patients With Hypogammaglobulinemia Secondary to Hematologic Malignancies: A Japanese Claims Database Study.免疫球蛋白替代疗法对血液系统恶性肿瘤继发低丙种球蛋白血症患者严重细菌感染的真实世界影响：一项日本索赔数据库研究
EJHaem. 2025 Jul 2;6(4):e70091. doi: 10.1002/jha2.70091. eCollection 2025 Aug.
7
X-Linked Lymphoproliferative DiseaseX连锁淋巴增殖性疾病
8
Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy.复发缓解型多发性硬化症患者血液和脑脊液中的单核吞噬细胞：未经治疗及接受抗CD20治疗的情况
J Neuroimmunol. 2025 Dec 15;409:578751. doi: 10.1016/j.jneuroim.2025.578751. Epub 2025 Sep 8.
9
Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.深刻性症状性低丙种球蛋白血症：利妥昔单抗治疗免疫性血小板减少症后的罕见迟发性并发症。3 例报告及文献系统评价。
Autoimmun Rev. 2014 Oct;13(10):1055-63. doi: 10.1016/j.autrev.2014.08.036. Epub 2014 Aug 27.
10
Rituximab in the COVID-19 era: The impact of albumin and IgG on patients with immune-mediated inflammatory diseases.利妥昔单抗在新冠疫情时代：白蛋白和免疫球蛋白对免疫介导的炎症性疾病患者的影响。
Clin Rheumatol. 2025 Jul 31. doi: 10.1007/s10067-025-07598-3.

本文引用的文献

1
Secondary hypogammaglobulinemia and lymphocytopenia in patients with inflammatory neurological diseases on anti-CD20 therapy: risk of infection and infection-related mortality.接受抗CD20治疗的炎性神经疾病患者的继发性低丙种球蛋白血症和淋巴细胞减少症：感染风险及感染相关死亡率
Neurol Sci. 2025 Jul 5. doi: 10.1007/s10072-025-08329-x.
2
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.免疫球蛋白水平、感染风险和死亡率与利妥昔单抗和低丙种球蛋白血症的关系。
JAMA Netw Open. 2018 Nov 2;1(7):e184169. doi: 10.1001/jamanetworkopen.2018.4169.
3
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
奥瑞珠单抗与安慰剂治疗原发性进行性多发性硬化症。
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.